Hutch News

Hutch News

Stories tagged 'B cell'

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 5, 2016

Applicants wanted for most inclusive fellowship program among top cancer centers; Dr. Oliver Press honored as new Giuliani/Press Endowed Chair; possible new path to targeted therapies for certain leukemias, myelodysplastic syndrome.

View story >


Good news at Fred Hutch: Celebrating our achievements

March 12, 2015 | By Fred Hutch staff

Notable accomplishments: Dr. Hans-Peter Kiem and colleagues explore new source of stem cells and gene therapy; Dr. Justin Taylor publishes a paper describing the path or paths individual naive B cells can take to maturity; Graduate student Nitobe London among 2015 Weintraub award winners

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.